BW Gestao de Investimentos Ltda. Has $14.51 Million Stake in Clarivate PLC $CLVT

BW Gestao de Investimentos Ltda. lifted its holdings in shares of Clarivate PLC (NYSE:CLVT) by 51.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,345,321 shares of the company’s stock after buying an additional 1,480,300 shares during the quarter. BW Gestao de Investimentos Ltda. owned about 0.66% of Clarivate worth $14,513,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. American Century Companies Inc. boosted its position in shares of Clarivate by 20.6% during the third quarter. American Century Companies Inc. now owns 9,973,797 shares of the company’s stock worth $38,200,000 after purchasing an additional 1,706,306 shares in the last quarter. Iridian Asset Management LLC CT boosted its position in shares of Clarivate by 52.4% during the fourth quarter. Iridian Asset Management LLC CT now owns 1,528,410 shares of the company’s stock worth $5,105,000 after purchasing an additional 525,452 shares in the last quarter. Cove Street Capital LLC boosted its position in shares of Clarivate by 4,075.2% during the third quarter. Cove Street Capital LLC now owns 452,462 shares of the company’s stock worth $1,733,000 after purchasing an additional 441,625 shares in the last quarter. LSV Asset Management bought a new position in shares of Clarivate during the third quarter worth $8,072,000. Finally, UBS Group AG boosted its position in shares of Clarivate by 21.6% during the fourth quarter. UBS Group AG now owns 3,271,921 shares of the company’s stock worth $10,928,000 after purchasing an additional 580,765 shares in the last quarter. Institutional investors and hedge funds own 85.72% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research report on Friday, March 27th. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Royal Bank Of Canada reduced their price target on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a research report on Wednesday, February 25th. Citigroup reduced their price target on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a report on Wednesday, March 4th. Finally, Barclays reduced their price target on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a report on Wednesday, February 25th. Five analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus target price of $3.22.

Clarivate Stock Performance

Shares of CLVT stock opened at $2.73 on Tuesday. The stock has a market cap of $1.74 billion, a P/E ratio of -12.98 and a beta of 1.37. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84. The company has a fifty day moving average price of $2.53 and a two-hundred day moving average price of $2.80. Clarivate PLC has a one year low of $1.66 and a one year high of $4.77.

Clarivate (NYSE:CLVT) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The company had revenue of $585.50 million for the quarter, compared to analyst estimates of $569.50 million. During the same period in the prior year, the firm earned $0.14 earnings per share. The company’s revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, equities analysts predict that Clarivate PLC will post 0.65 EPS for the current year.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.